LABORATORY RESEARCH USE ONLY β This compound is NOT for human consumption, veterinary use, or therapeutic applications.
Bioregulator PeptidesMusculoskeletal Research㪠RUO
Cartalax
Molecular Data
Formula
C12H23N3O7
Mol. Weight
317.00 Da
CAS Number
N/A
Purity
β₯95%
Appearance
White powder
Storage
-20Β°C, desiccated
Amino Acid Sequence
Ala-Glu-Asp
Research Overview
Cartalax is a synthetic tripeptide bioregulator targeting cartilage and musculoskeletal tissue gene expression.
Mechanism of Action
Modulates chondrocyte gene expression, promoting proteoglycan synthesis and collagen type II production in cartilage tissue.
Research Applications
Cartilage biology, osteoarthritis modeling, chondrocyte differentiation, joint tissue regeneration, musculoskeletal aging.
Key Research Findings
Enhanced proteoglycan synthesis in chondrocyte cultures. Improved cartilage matrix integrity in aging tissue models.
MANDATORY DISCLAIMER: Cartalax as referenced on this page is strictly for in-vitro laboratory research and forensic applications only. It is NOT for human consumption, veterinary use, diagnostic purposes, therapeutic applications, or any form of bodily introduction. Any reference to research outcomes pertains exclusively to controlled laboratory settings. Researchers must comply with all applicable local, state, and federal regulations.
